MOL CANCER RES 润色咨询

MOLECULAR CANCER RESEARCH

出版年份:2002 年文章数:2177 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:2.1% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=ac207004, cover=https://img.medsci.cn/images/journal/cover/2021/EfX_202109271316060910.jpg, fullname=MOLECULAR CANCER RESEARCH, abbr=MOL CANCER RES, pyear=2002, frequence=Monthly, articleNumbers=2177, citedSelf2015=2.1, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均0.67月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1541-7786, greenSci=https://www.greensci.net/search?kw=1541-7786, scijournal=https://www.scijournal.org/impact-factor-of-MOL-CANCER-RES.shtml, medsciHotlightString=null, medsciHotlightRealtime=9.781, medsciHotlight=16.276, medsciHotlight5year=17.5309, citescore=8.7, hIndex=135, impactFactor=5.2, orgnization=American Association for Cancer Research Inc., orgnizationUrl=http://www.aacr.org/, country=United States, countryCn=美国, isOa=0, isOaString=否, sciScie=Science Citation Index|Science Citation Index Expanded|Current Contents - Life Sciences|BIOSIS Previews, bigclassCas=医学 2区, smallclassCas=医学 2 区, website=http://mcr.aacrjournals.org/, websiteHits=18475, guideForAuthor=http://mcr.aacrjournals.org/site/misc/journal_ifora.xhtml, guideForAuthorHits=903, submitWebsite=https://mcr.msubmit.net/cgi-bin/main.plex, submitWebsiteHits=5044, content=<p style="-webkit-font-smoothing: antialiased; margin: 0px 0px 15px; padding: 0px; border: 0px; outline: 0px; vertical-align: baseline; font-stretch: inherit;"><span style="border-style: initial; border-color: initial; border-image-source: initial; border-image-slice: initial; border-image-width: initial; border-image-outset: initial; border-image-repeat: initial; font-stretch: inherit;">Molecular Cancer Research</span> publishes articles describing novel basic cancer research discoveries of broad interest to the field. Studies must be of demonstrated significance, and the journal prioritizes analyses performed at the molecular and cellular level that reveal novel mechanistic insight into pathways and processes linked to cancer risk, development, and/or progression. Areas of emphasis include all cancer-associated pathways (including cell-cycle regulation; cell death; chromatin regulation; DNA damage and repair; gene and RNA regulation; genomics; oncogenes and tumor suppressors; and signal transduction), in addition to studies describing new molecular mechanisms and interactions that support cancer phenotypes. For full consideration, primary research submissions must provide significant novel insight into existing pathway functions or address new hypotheses associated with cancer-relevant biologic questions.</p><h2 style="-webkit-font-smoothing: antialiased; margin: 15px 0px; padding: 0px; border: 0px; outline: 0px; vertical-align: baseline; font-stretch: inherit;"><manuscript submission="" style="-webkit-font-smoothing: antialiased;"></manuscript></h2><p style="-webkit-font-smoothing: antialiased; margin: 0px 0px 15px; padding: 0px; border: 0px; outline: 0px; vertical-align: baseline; font-stretch: inherit;"><span style="border-style: initial; border-color: initial; font-stretch: inherit;">Molecular Cancer Research</span> accepts submissions of primary research, review and commentary article types as well as letters to the editor. For descriptions and length requirements of the article types available to submitting authors see the <a href="http://mcr.aacrjournals.org/site/misc/journal_ifora.xhtml" style="-webkit-font-smoothing: antialiased; margin: 0px; padding: 0px; border: 0px; outline: 0px; vertical-align: baseline; font-stretch: inherit;">Categories of Articles</a> for <span style="border-style: initial; border-color: initial; font-stretch: inherit;">Molecular Cancer Research</span>. The AACR Journals all use a similar Editorial Process. Please note that <span style="border-style: initial; border-color: initial; font-stretch: inherit;">Molecular Cancer Research</span> does not consider appeals.</p><p style="-webkit-font-smoothing: antialiased; margin: 0px 0px 15px; padding: 0px; border: 0px; outline: 0px; vertical-align: baseline; font-stretch: inherit;">Submitting authors must be familiar with the <a href="http://www.aacrjournals.org/site/InstrAuthors/ifora.xhtml#editorialprocess" style="-webkit-font-smoothing: antialiased; margin: 0px; padding: 0px; border: 0px; outline: 0px; vertical-align: baseline; font-stretch: inherit;">Editorial Policies</a> of the AACR Journals covering important information on authorship, publishing ethics, availability of materials and data and data analysis and reporting.</p><p style="-webkit-font-smoothing: antialiased; margin: 0px 0px 15px; padding: 0px; border: 0px; outline: 0px; vertical-align: baseline; font-stretch: inherit;">Manuscripts are stringently reviewed for high standards of scientific merit, and only those that report results of novel, timely, and broadly-significant research are accepted for publication.</p>, totalCites=11324, brief=MOL CANCER RES杂志医学行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=细胞生物学" >细胞生物学</a></strong>”子行业的中等级别杂志, articleType=论著为主,其它类型文章约占5-10%, medsciHeat=<span style="color: #990000;">暗红</span>, medsciComment=MOL CANCER RES杂志级别还可以,但是相对来说,比较冷门,关注人数偏少,有些可能是国内不太熟悉,但该杂志在国际仍然有相当知晓度的。因为缺少中国人投稿,稿源可能未必丰富,发表有可能有很大的机会哦。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=ac207004'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=9), ImpactFactorTagDto(id=57697, tagName=autophagy, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=4.89), GetImpactFactorCiteScoreListResponse(year=2017, citescore=4.65), GetImpactFactorCiteScoreListResponse(year=2018, citescore=4.67), GetImpactFactorCiteScoreListResponse(year=2019, citescore=7.1), GetImpactFactorCiteScoreListResponse(year=2020, citescore=8.7)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=18.794), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=16.837), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=14.685), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=10.873), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=9.781)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Oncology , rank=45/321), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Molecular Biology , rank=69/375), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Cancer Research , rank=42/191)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=CELL BIOLOGY, rank=Q2), GetImpactFactorCiteScoreGradeResponse(smallClass=ONCOLOGY, rank=Q1)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1541-7786[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=MOLECULAR CANCER RESEARCH[ta], article_number=146, article_number_cn=19, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
MOL CANCER RES/MOLECULAR CANCER RESEARCH
ISSN
1541-7786
影响指数话题
预警等级
MedSci期刊指数
9.781 (MedSci实时期刊指数) | 17.5309 (5年期刊指数)
CiteScore值
8.7
h-index
135
h5-median
暂无数据
出版社/管理机构
出版国家/地区
United States 美国
出版周期
Monthly
出版年份
2002
是否OA
被收录情况
Science Citation Index|Science Citation Index Expanded|Current Contents - Life Sciences|BIOSIS Previews
JCR分区
CELL BIOLOGY Q2
ONCOLOGY Q1
中科院分区
大类:医学 2区
小类:医学 2 区